Cardiovascular Medicine

1 pages, 67 KB

Open AccessCommunication

Jahresbericht 2008 der Arbeitsgruppe «Herzschrittmacher und Elektrophysiologie» der SGK

by Urs Bauersfeld

Cardiovasc. Med. 2009, 12(7), 222; https://doi.org/10.4414/cvm.2009.01436 - 14 Aug 2009

Viewed by 59

Die Arbeitsgruppe Herzschrittmacher und Elektrophysiologie verzeichnete im Berichtsjahr 2008 einen weiteren Mitgliederzuwachs auf 229 Mitglieder [...] Full article

2 pages, 435 KB

Open AccessInteresting Images

Tachycardie à QRS Large Sous Propafenone

by Stéphane Noble and Laurent Macle

Cardiovasc. Med. 2009, 12(7), 220; https://doi.org/10.4414/cvm.2009.01435 - 14 Aug 2009

Viewed by 50

Abstract

Une patiente de 73 ans, connue pour une hypertension artérielle et une dyslipidémie présente un flutter auriculaire symptomatique récidivant sur coeur structurellement normal [..] Full article

► Show Figures

Figure 1

6 pages, 206 KB

Open AccessEditorial

Vareniclin: Eine Hoffnung in der Rauchentwöhnung?

by Urs Jeker and Paul Erne

Cardiovasc. Med. 2009, 12(7), 214; https://doi.org/10.4414/cvm.2009.01434 - 14 Aug 2009

Viewed by 92

Abstract

Varenicline, a partial agonist of α₄β₂ nicotinic acetylcholine receptors, is the most recently approved drug for smoking cessation. Varenicline triples the abstinence rates compared with placebo, and is statistically more effective for smoking cessation over one year follow- up than the alternative active treatments, Bupropion or nicotine replacement therapy (NRT). The higher reduction of craving and withdrawal symptoms as well as “compensation” of some of the “positive sensations” associated with smoking are probably explained by the proposed partial agonist/antagonist effects of varenicline. This concept of a dual mechanism may be helpful in converting new insights regarding individual patterns of nicotine consumption into novel therapeutic strategies. With negligible pharmacokinetic interactions varenicline is generally well tolerated, however neuropsychiatric side effects in particular may limit the application. There are insufficient results on safety analyses to draw conclusions at the time of writing. Full article

► Show Figures

Figure 1

5 pages, 151 KB

Open AccessEditorial

Carotid Artery Dissection and Sports

by Marcel Arnold, Urs Fischer and Krassen Nedeltchev

Cardiovasc. Med. 2009, 12(7), 209; https://doi.org/10.4414/cvm.2009.01439 - 14 Aug 2009

Cited by 2 | Viewed by 90

Abstract

Carotid artery dissection (CAD) is a potentially lifethreatening disease and mainly affects young and middle- aged people. In recent years dissections have been diagnosed more frequently, probably because new imaging techniques allow more reliable diagnosis. The cause of so-called spontaneous CAD is largely unexplained. It most likely involves an underlying abnormality of the vessel wall and triggering factors such as infection, minor trauma or sporting activities. Various sporting activities have been reported in association with CAD. Nevertheless, the causal relationship between sporting activities and CAD often remains doubtful. Traumatic CAD mainly complicates severe blunt head or neck traumas, which are often due to motor vehicle or sport accidents.
The clinical presentations of CAD are highly variable. Headache, neck and facial pain, pulsatile tinnitus, Horner’s syndrome, cranial nerve palsies, stroke, TIA, retinal infarction, or transient monocular blindness, may be present in isolation or in various combinations. Ischaemic symptoms are often preceded by local symptoms or signs. The knowledge and recognition of these symptoms and the often subtle signs are the keys to an early diagnosis and antithrombotic treatment of ICAD before severe ischaemic complications occur. The longterm prognosis of CAD is favourable in the majority of patients. Clinical functional outcome mainly depends on the initial stroke severity. Symptomatic recurrent dissections and recurrent strokes are rare. Full article

► Show Figures

Figure 1

4 pages, 121 KB

Open AccessProceeding Paper

Key Messages: Cardiovascular Imaging 2008

by Michael Zellweger and Christine H. Attenhofer Jost

Cardiovasc. Med. 2009, 12(7), 205; https://doi.org/10.4414/cvm.2009.01437 - 14 Aug 2009

Viewed by 67

Abstract

In cardiovascular imaging, every year there are exciting new findings and advances. This was also obvious at the Swiss Society of Cardiology Meeting 2008 in Berne. In this article we summarise the findings of the most important international and especially national studies in the fields of echocardiography, cardiac MRI and computed tomography presented at this meeting. Among the total of 279 abstracts, the number of accepted abstracts in the field of cardiac imaging included 14 abstracts especially focussed on echocardiography, 5 on cardiac MRI, 4 on computed tomography and 4 on myocardial perfusion SPECT. In this article, we especially deal with the topics of cardiac resynchronisation, 3D echocardiography, contrast echocardiography, and the most important presentations regarding cardiac MRI, computed tomography, and myocardial perfusion imaging. Increasingly, molecular and hybrid imaging like PET-CT will be part of modern cardiology. This meeting showed that we get closer to the goal of perfect diagnosis and prognosis in cardiology. However, there are some caveats regarding cardiac imaging especially the problem of radiation exposure as well as discussion regarding costs and usefulness of multimodality imaging. Full article

► Show Figures

Figure 1

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 12, Issue 7 (08 2009) – 5 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI